tegafur has been researched along with Intestinal Diseases in 2 studies
Intestinal Diseases: Pathological processes in any segment of the INTESTINE from DUODENUM to RECTUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sumiyoshi, M | 1 |
| Suzuki, T | 1 |
| Kimura, Y | 1 |
| Takechi, T | 1 |
| Nakano, K | 1 |
| Uchida, J | 1 |
| Mita, A | 1 |
| Toko, K | 1 |
| Takeda, S | 1 |
| Unemi, N | 1 |
| Shirasaka, T | 1 |
2 other studies available for tegafur and Intestinal Diseases
| Article | Year |
|---|---|
Protective effects of water-soluble low-molecular-weight beta-(1,3-1,6)d-glucan purified from Aureobasidium pullulans GM-NH-1A1 against UFT toxicity in mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Basidiomycota; beta-Glucans; Cell Line, Tum | 2009 |
Antitumor activity and low intestinal toxicity of S-1, a new formulation of oral tegafur, in experimental tumor models in rats.
Topics: Animals; Antimetabolites, Antineoplastic; Colonic Neoplasms; Drug Combinations; Drug Screening Assay | 1997 |